BRWXF yields 1538.46% · PFE yields 6.13%● Live data
📍 BRWXF pulled ahead of the other in Year 1
Combined, BRWXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BRWXF + PFE for your $10,000?
Brunswick Exploration Inc. focuses on the exploration and development of gold and base metal properties in eastern Canada. The company has an option to acquire interest up to 51% in the Brunswick Belt exploration property that covers an area of 72 kilometers located in the Bathurst Mining Camp in New Brunswick; and holds interest in the Fundy Gold project, a gold-silver property covering an area of 37,260 hectares located in southern New Brunswick. It also has an option to acquire a 100% interest in the Lac Édouard nickel-copper project comprising 25 claims covering an area of 1,374.5 hectares located northeast of the town of La Tuque, Quebec. The company was formerly known as Komet Resources Inc. and changed its name to Brunswick Exploration Inc. in October 2020. Brunswick Exploration Inc. is headquartered in Montreal, Canada.
Full BRWXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.